ÂÜÀòÂÒÂ×

Andrew Sage is a professional with extensive experience in biochemistry and biotechnology, currently serving as Team Leader at RXCELERATE LIMITED since November 2021. Prior to this role, Andrew held the position of Research Fellow at the University of Cambridge from July 2010 to November 2021, focusing on a British Heart Foundation fellowship centered on the pathogenic role of B cells in Atherosclerosis. Additionally, Andrew contributed as a Volunteer in RNA extraction at the Cambridge COVID testing centre in 2020 and completed a Postdoctoral Fellowship at UCLA Medical Center from March 2008 to July 2010. Educational credentials include a PhD in Biochemistry and a BSc in Biochemistry and Biotechnology from The University of Manchester.